• drapreau en
  • drapreau fr
    1. Scientific & B2B Programme
    2. Programme


    Programme

  •              

    Preliminary programme up to date 30 Oct. 2019

  • Detailed programme & abstracts

    14:00 - 15:00 - Douglas HANAHAN, Swiss Institute For Experimental Cancer, Research (Isrec),, Switzerland
    15:00 - 16:00 - Hypoxia, Metabolism, and Tumor Progression
    M. Celeste SIMON, Abramson Family Cancer Research Institute, United States
    16:00 - 17:00 - Hervé AVET-LOISEAU, Cancer Research Center Of Toulouse (Crct),
    Session 1 :  Can we really improve DNA damaging agents efficacy ?
    09:00 - 09:40 - Precision Medicine with DNA-targeted agents
    Yves POMMIER, Developmental Therapeutics Branch And Laboratory Of Molecular Pharmacology, Usa
    09:40 - 09:55 - Short communication
    Selected ABSTRACT, ,
    09:55 - 10:35 - Madalena TARSOUNAS, University Of Oxford, United Kingdom
    10:35 - 11:05 - Coffee break - Poster session
    11:05 - 11:20 - Short communication
    Selected ABSTRACT, ,
    11:20 - 11:35 - Short communication
    Selected ABSTRACT, ,
    11:35 - 12:15 - From DNA repair mechanisms to drug discovery
    Sébastien BRITTON, Ipbs Cnrs Toulouse, France
    Session 2 :  Targeted therapies and resistance mechanisms
    14:15 - 14:55 - Fabrice ANDRÉ, Gustave Roussy, France
    14:55 - 15:10 - Short communication
    Selected ABSTRACT, ,
    15:10 - 15:50 - Targeting PI3K isoforms in pancreatic cancer: novel concepts of cooperation / competition in signalling nodes.
    Julie GUILLERMET-GUIBERT, Cancer Research Center Of Toulouse (Crct), France
    15:50 - 16:20 - Coffee break - Poster session
    16:20 - 16:35 - Short communication
    Selected ABSTRACT, ,
    16:35 - 16:50 - Short communication
    Selected ABSTRACT, ,
    16:50 - 17:30 - Nongenetic mechanisms of tumor evolution and therapy resistance
    Jean-Christophe MARINE, Vib Ku Leuven Center For Cancer Biology, Belgium
    Session 3 :  Translating oncoimmunology science into survival 
    09:00 - 09:40 - Nikhil C. MUNSHI, Dana Farber Institute, Medical Oncology, United States
    09:40 - 09:55 - Short communication
    Selected ABSTRACT, ,
    09:55 - 10:35 - Jean-Jacques FOURNIE, Cancer Research Center Of Toulouse (Crct),
    10:35 - 11:05 - Coffee break - Poster session
    11:05 - 11:20 - Short communication
    Selected ABSTRACT, ,
    11:20 - 11:35 - Short communication
    Selected ABSTRACT, ,
    11:35 - 12:15 - Harnessing innate immunity in cancer
    Eric VIVIER, Centre D'immunologie Marseille-Luminy, France
    Session 4 : Metabolic vulnerabilities–driven therapies 
    14:15 - 14:55 - Marina KONOPLEVA, Md Anderson Cancer Center,
    14:55 - 15:10 - Short communication
    Selected ABSTRACT, ,
    15:10 - 15:50 - Mitochondria and Cancer
    Christian FREZZA, Mrc Cancer Unit, University Of Cambridge, United Kingdom
    15:50 - 16:20 - Coffee break - Poster session
    16:20 - 16:35 - Short communication
    Selected ABSTRACT, ,
    16:35 - 16:50 - Short communication
    Selected ABSTRACT, ,
    16:50 - 17:30 - Roles of the p53 pathway in metabolism: implications in aging, tissue homeostasis and carcinogenesis
    Laurent LE CAM, Institut De Recherche En Cancérologie De Montpellier, France
    Organisation des territoires et recensement des structures
    • Loi santé et organisation territoriale
    • Etat des lieux des dispositifs de coordination ville hôpital en Occitanie
    • Retours d’expériences de coordination ville hôpital en cancérologie
    Comment le réseau peut accompagner les territoires pour favoriser la coordination ville hôpital pour les patients atteints de cancer ?

    Quels outils existent pour faciliter la coordination ville hôpital des patients atteints de cancer en Occitanie